)
Edge15 May 2026
TOMRA: Closing the Loop
The story of TOMRA: from reverse vending machine pioneer to global technology for deposit systems, recycling, and resource optimization.
Celltrion
Celltrion (068270) investor relations material
Celltrion Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary6 May, 2026
Executive summary
Revenue grew 36% year-over-year in Q1 2026, driven by rapid uptake of five new product launches and strong growth in high-margin young products.
Operating profit more than doubled year-over-year, with margin improvement attributed to a favorable sales mix and normalization of merger-related impacts.
High-margin young biologics products accounted for 60% of total revenue, with expectations to reach 70% for FY2026.
Non-biologics revenue surged 130% year-over-year, primarily due to TEVA CMO revenue.
Financial highlights
Q1 2026 sales: KRW 1,145.0bn (+36% YoY, -13.9% QoQ); Biologics: KRW 974.2bn (+26.9% YoY); Non-biologics: KRW 170.8bn (+129.9% YoY).
Operating profit: KRW 321.9bn (+115.5% YoY, -32.3% QoQ); OP margin: 28.1% (+10.4%p YoY).
Net profit: KRW 350bn (30.6% margin), up from KRW 108bn (12.9% margin) in Q1 2025.
Gross profit margin improved to 59.9% in Q1 2026 from 52.6% in Q1 2025.
Outlook and guidance
Sustained profitability improvement expected from further penetration of new launches, geographic expansion, and production process optimization.
Quarterly operating profit growth anticipated, driven by high-margin product expansion and normalized U.S. plant operations.
Additional margin upside expected from raw material localization and economies of scale.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Celltrion
- Record revenue and profit growth in 2025, with 2026 guidance targeting 26% higher sales.068270
Q4 20251 Mar 2026 - Accelerating innovation and CDMO growth with robust pipeline and enhanced shareholder returns.068270Investor Day 20243 Feb 2026
- Record sales and profit growth fueled by young biologics and global expansion.068270Q3 202516 Nov 2025
- Record profit and margin gains fueled by young biologics and portfolio optimization.068270Q2 202517 Aug 2025
- Record revenue growth in 2024, but profit declined post-merger; margin recovery expected in 2025.068270Q4 20242 Jul 2025
- Record revenue growth offset by lower profit and margins amid merger and higher costs.068270Q2 202413 Jun 2025
- Record sales growth and expanding global leadership fueled by biosimilars and novel drugs.068270Investor Presentation13 Jun 2025
- Record sales and rapid biosimilar growth position Celltrion as a top-tier global pharma.068270Investor Presentation13 Jun 2025
- 1Q25 revenue and profit soared on young portfolio growth, with robust 2025 outlook.068270Q1 20256 Jun 2025
Celltrion
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage